1-(3-trifluoromethylphenyl)piperazine
GPTKB entity
Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
piperazine derivative |
| gptkbp:abbreviation |
gptkb:TFMPP
|
| gptkbp:actsOn |
serotonin receptor agonist
|
| gptkbp:CASNumber |
15532-75-5
|
| gptkbp:chemicalFormula |
C11H13F3N2
|
| gptkbp:effect |
Hallucinogen
entactogen stimulant |
| gptkbp:hasSMILES |
FC(F)(F)c1cccc(c1)N2CCNCC2
|
| https://www.w3.org/2000/01/rdf-schema#label |
1-(3-trifluoromethylphenyl)piperazine
|
| gptkbp:IUPACName |
1-(3-(trifluoromethyl)phenyl)piperazine
|
| gptkbp:legalStatus |
controlled substance in some countries
|
| gptkbp:molecularWeight |
230.23 g/mol
|
| gptkbp:often_found_in_combination_with |
gptkb:benzylpiperazine
|
| gptkbp:PubChem_CID |
71199
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:UNII |
1E8K1N1A4F
|
| gptkbp:usedFor |
recreational drug
|
| gptkbp:bfsParent |
gptkb:TFMPP
|
| gptkbp:bfsLayer |
8
|